Companies
Ynsect
the French mealworm-bioconversion pioneer, which raised over €500 million and built the FARMYNG flagship plant, was reported in January 2026 to have collapsed into insolvency after high production costs and over-scaling.
- Country
- France
- Ticker
- Euronext: ALYN
Coverage
| CN | EU | IN | US | |
|---|---|---|---|---|
| bioremediation | ✓ | ✓ | — | ✓ |
| food-alt-protein | — | ✓ | ✓ | ✓ |
Regulatorsefsafdaepaadememoa-china
Verifiable facts
| Fact | Value | Source |
|---|---|---|
| Funding | over €500 million / over $600 million | agfundernews.com · demstate.com · igrownews.com · techcrunch.com · agnavigator.com |
| Capacity | up to 30 tonnes/month at Dole pilot site; Amiens plant planned for over 1,500 tonnes/month and 160,000 tonnes annually | cordis.europa.eu · cbe.europa.eu |
| Certification | ISO 9001 certification | ynsect.com |
| Regulatory approval | marketing approval for insect-based fertilizer (ŸnFrass) from ANSES (March 2020); EFSA deemed mealworms safe for human consumption (January 2021) | cordis.europa.eu · cbe.europa.eu |
| Production site | Dole (pilot site), Amiens (flagship plant), Genopole biocluster | agfundernews.com · cordis.europa.eu · igrownews.com · ynsect.com |
| Headcount | exceeded 100 employees; approximately 360 employees in 2023 | cbe.europa.eu |
| Revenue | €17.8 million (2021 peak); €568,000 (2022); €5.8 million (2023) | igrownews.com · techcrunch.com |
Independent sources: agfundernews.com · agnavigator.com · cbe.europa.eu · cordis.europa.eu · demstate.com · igrownews.com · techcrunch.com
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Industrial insect farming | food-alt-protein | High | → |
| Upcycling biowaste into valuable products | bioremediation | Medium | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.